Pharma package delay disappoints EFPIA
This article was originally published in Scrip
Executive Summary
EFPIA, the European pharmaceutical industry association, regrets the European Commission's delay in issuing its package of pharmaceutical legislation. The commission was expected to release a series of proposals on allowing companies to communicate directly with patients, pharmacovigilance and anti-counterfeiting measures, along with a communication on the future of the EU single market in pharmaceuticals, but this has been postponed indefinitely (Scrip Online, October 22nd, 2008).